These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee. Hum Gene Ther; 2002 Jan; 13(1):3-13. PubMed ID: 11779411 [No Abstract] [Full Text] [Related]
6. In memoriam: tougher rules could be the legacy of gene therapy's first death. Boyce N New Sci; 1999 Dec; 164(2217):9. PubMed ID: 11902198 [No Abstract] [Full Text] [Related]
7. Gene therapy trials face further scrutiny. Greener M Mol Med Today; 2000 Jun; 6(6):211. PubMed ID: 10840374 [No Abstract] [Full Text] [Related]
12. Who needs to know? Confusion reigns over the reporting of gene therapy deaths. Boyce N New Sci; 1999 Nov; 164(2212):15. PubMed ID: 11885629 [No Abstract] [Full Text] [Related]
13. Panel seeks better monitoring of experiments using people. Hilts PJ N Y Times Web; 2000 Mar; ():A20. PubMed ID: 11873787 [No Abstract] [Full Text] [Related]
14. Clinical medicine. FDA to release data on gene therapy trials. Kaiser J Science; 2001 Jan; 291(5504):572-3. PubMed ID: 11229395 [No Abstract] [Full Text] [Related]
16. Recombinant DNA Advisory Committee. U.S. Department of Health and Human Services, Public Health Service, National Institute of Health. Hum Gene Ther; 2001 Nov; 12(17):2129-51. PubMed ID: 11747602 [No Abstract] [Full Text] [Related]
17. Gene therapy. FDA moves against Penn scientist. Vogel G Science; 2000 Dec; 290(5499):2049-51. PubMed ID: 11187817 [No Abstract] [Full Text] [Related]
18. Gene therapy's second act. Lewis R Sci Am; 2014 Mar; 310(3):52-7. PubMed ID: 24660328 [No Abstract] [Full Text] [Related]